Primary nasal polyposis. 1983

R L Jacobs, and A J Freda, and W G Culver

Twenty patients with nasal polyposis, either asymptomatic or with persistent nasal obstruction, were studied prospectively. Fourteen of 18 patients when free of obstructing polyps had no ongoing nasal symptoms. Nasal secretion eosinophilia of greater than or equal to 20% was demonstrated in 19/20 patients. Prick skin tests and RAST were positive to inhalant allergens with poor clinical correlation in 10/20 patients. Mean total eosinophil count and mean total serum IgE, IgA, IgG and IgM were normal. Sinus roentgenograms were consistent with sinusitis in 11/20 patients. Methacholine bronchial provocation was positive in 11/19 patients. Aspirin challenge was negative to 650 mg and 3250 mg in 18/18 and 8/8 patients respectively. Serum salicylate levels two hours post 3250 mg aspirin challenge had a mean of 18.5 mg/dl. HLA typing to the A and B loci revealed no specific pattern. Patients with primary nasal polyposis are characterized by nasal secretion eosinophilia, lack of ongoing symptoms when free of obstructing polyps, increased frequency of cholinergic bronchial hyper-reactivity, increased susceptibility to recurrent or chronic sinusitis, lack of aspirin sensitivity and high frequency of inhalant prick skin test and RAST positivity without correlation to symptoms. These patients may represent a variant of the syndrome involving nasal polyposis, bronchial asthma and bronchospastic reactions to aspirin and related drugs.

UI MeSH Term Description Entries
D008297 Male Males
D008688 Methacholine Compounds A group of compounds that are derivatives of beta-methylacetylcholine (methacholine). Compounds, Methacholine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009298 Nasal Polyps Focal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations. Nasal Polyp,Polyp, Nasal,Polyps, Nasal
D001985 Bronchial Provocation Tests Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma. Allergen Bronchial Provocation Tests,Allergen Challenge, Endobronchial,Antigen Bronchial Provocation Tests,Bronchial Allergen Challenge,Bronchial Challenge Tests,Inhalation Provocation Tests,Provocation Tests, Bronchial,Endobronchial Challenge Tests,Allergen Challenge, Bronchial,Allergen Challenges, Bronchial,Allergen Challenges, Endobronchial,Bronchial Allergen Challenges,Bronchial Challenge Test,Bronchial Provocation Test,Challenge Test, Bronchial,Challenge Test, Endobronchial,Challenge Tests, Bronchial,Challenge Tests, Endobronchial,Challenge, Bronchial Allergen,Challenge, Endobronchial Allergen,Challenges, Bronchial Allergen,Challenges, Endobronchial Allergen,Endobronchial Allergen Challenge,Endobronchial Allergen Challenges,Endobronchial Challenge Test,Inhalation Provocation Test,Provocation Test, Bronchial,Provocation Test, Inhalation,Provocation Tests, Inhalation,Test, Bronchial Challenge,Test, Bronchial Provocation,Test, Endobronchial Challenge,Test, Inhalation Provocation,Tests, Bronchial Challenge,Tests, Bronchial Provocation,Tests, Endobronchial Challenge,Tests, Inhalation Provocation
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

R L Jacobs, and A J Freda, and W G Culver
June 1960, L'union medicale du Canada,
R L Jacobs, and A J Freda, and W G Culver
October 1969, Postgraduate medical journal,
R L Jacobs, and A J Freda, and W G Culver
November 1959, Medical times,
R L Jacobs, and A J Freda, and W G Culver
January 2012, Duodecim; laaketieteellinen aikakauskirja,
R L Jacobs, and A J Freda, and W G Culver
January 1964, Les Cahiers du College de medecine des hopitaux de Paris,
R L Jacobs, and A J Freda, and W G Culver
December 1990, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society,
R L Jacobs, and A J Freda, and W G Culver
December 1990, The Journal of allergy and clinical immunology,
R L Jacobs, and A J Freda, and W G Culver
August 1961, Archives of otolaryngology (Chicago, Ill. : 1960),
R L Jacobs, and A J Freda, and W G Culver
March 2019, La Revue du praticien,
R L Jacobs, and A J Freda, and W G Culver
January 1949, Afrique francaise chirurgicale,
Copied contents to your clipboard!